Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › TRVI

SUPERSTRING CAPITAL MANAGEMENT LP position in TRVI

TREVI THERAPEUTICS INC · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 524,224 shares of TRVI (TREVI THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$9.8M, representing 6.17% of its reported portfolio and ranking #5 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed TRVI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)524.22K sh
Reported value held$9.78M
Portfolio Weight6.17%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's TRVI position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in TRVI in Q4 2025 at 148,292 shares (US$1.9M). The position peaked in Q2 2026 at 524,224 shares, worth US$9.8M. Across 3 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 524,224 shares valued at US$9.8M — an increase of 272,658 shares quarter over quarter.. Notable position changes include a 70% increase in Q1 2026 (shares rose 56% over the following quarter), a 108% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 148.29K $1.86M New
Q1 2026 251.57K $3.00M Add
Q2 2026 524.22K $9.78M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$95.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held TRVI?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed TRVI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in TRVI?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 524.22K shares of TRVI (TREVI THERAPEUTICS INC), valued at $9.78M, representing 6.17% of its reported portfolio and ranking #5.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling TRVI?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in TRVI. The position peaked in Q2 2026 at 524.22K shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.